Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1406, 2003-01, pp. : 5-6
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Hepatitis B significant cost burden in Asia
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 431, 2003-01 ,pp. :
Access to resources
Recommend
Global perspective of the burden of chronic hepatitis B
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 469, 2005-01 ,pp. :
Hepatitis B news from the 2nd Asia-Pacific ISPOR conference
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 499, 2006-01 ,pp. :
Cost-Effectiveness Analysis of Lamivudine for the Treatment of Chronic Hepatitis B
By Crowley S.J.
PharmacoEconomics, Vol. 17, Iss. 5, 2000-05 ,pp. :
IM hepatitis B immune globulin cost saving after liver transplantation
Inpharma, Vol. 1, Iss. 1396, 2003-01 ,pp. :